Wordt geladen...
ECF chemotherapy for liver metastases due to castration-resistant prostate cancer
INTRODUCTION: Most men with metastatic castration-resistant prostate cancer (CRPC) have biochemical response to docetaxel, but the objective response rate is low. Liver metastases are uncommon with CRPC and associated with shorter survival. More active treatment might benefit these patients. Epirubi...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Canadian Medical Association
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4216294/ https://ncbi.nlm.nih.gov/pubmed/25408803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2029 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|